| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10914768 | Molecular Oncology | 2013 | 11 Pages |
Abstract
Oncolytic vvDD administered i.v. shows activity in preclinical models of pediatric malignancies that are resistant to many currently available treatments. Our data support further evaluation of vvDD virotherapy for refractory pediatric solid tumors.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Xueqing Lun, Yibing Ruan, Aarthi Jayanthan, David J. Liu, Anjali Singh, Tanya Trippett, John Bell, Peter Forsyth, Randal N. Johnston, Aru Narendran,